Comparison of Burnet's clonal selection theory with tumor cell-clone development
- PMID: 29930737
- PMCID: PMC6010991
- DOI: 10.7150/thno.24083
Comparison of Burnet's clonal selection theory with tumor cell-clone development
Abstract
Increasing evidence has shown that Darwin's theory of evolution provides vital insights into the emergence and etiology of different types of cancer. On a microscopic scale, cancer stem cells meet the conditions for the Darwinian process of natural selection. In particular, cancer stem cells undergo cell reproduction characterized by the emergence of heritable variability that promotes replication and cell survival. Methods: Evidence from previous studies was gathered to compare Burnet's clonal selection theory with the tumor evolution theory. Results: The findings show that the Darwinian theory offers a general framework for understanding fundamental aspects of cancer. As fundamental theoretical frameworks, Burnet's clonal selection theory and the tumor evolution theory can be used to explain cancer cell evolution and identify the beneficial adaptations that contribute to cell survival in tissue landscapes and tissue ecosystems. Conclusions: In conclusion, this study shows that both Burnet's clonal selection theory and the tumor evolution theory postulate that cancer cells in tissue ecosystems evolve through reiterative processes, such as clonal expansion, clonal selection, and genetic diversification. Therefore, both theories provide insights into the complexities and dynamics of cancer, including its development and progression. Finally, we take into account the occurrence of biologic variation in both tumor cells and lymphocytes. It is important to note that the presence of lymphocyte variations appears to be advantageous in the framework of tumor defense but also dangerous within the framework of autoimmune disease development.
Keywords: Burnet; cell clone theory; evolution; lymphocyte proliferation; tumor development.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interest exists.
Similar articles
-
Clonal evolution in cancer.Nature. 2012 Jan 18;481(7381):306-13. doi: 10.1038/nature10762. Nature. 2012. PMID: 22258609 Free PMC article. Review.
-
Cancer research meets evolutionary biology.Evol Appl. 2009 Feb;2(1):62-70. doi: 10.1111/j.1752-4571.2008.00063.x. Evol Appl. 2009. PMID: 25567847 Free PMC article.
-
A seminal monograph: Mackay and Burnet's Autoimmune diseases.Med J Aust. 2012 Jan 16;196(1):74-6. doi: 10.5694/mja11.10821. Med J Aust. 2012. PMID: 22256941
-
To portray clonal evolution in blood cancer, count your stem cells.Blood. 2021 Apr 8;137(14):1862-1870. doi: 10.1182/blood.2020008407. Blood. 2021. PMID: 33512426
-
Clonal selection parallels between normal and cancer tissues.Trends Genet. 2023 May;39(5):358-380. doi: 10.1016/j.tig.2023.01.007. Epub 2023 Feb 24. Trends Genet. 2023. PMID: 36842901 Review.
Cited by
-
Fine-grained simulations of the microenvironment of vascularized tumours.Sci Rep. 2019 Aug 12;9(1):11698. doi: 10.1038/s41598-019-48252-8. Sci Rep. 2019. PMID: 31406276 Free PMC article.
References
-
- Torre L, Bray F, Siegel R, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics. CA: A Cancer Journal for Clinicians. 2015;65(1):87–108. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials